Author

Ebiowei Samuel F Orubu

Observed names: E Sam Orubu, E Sf Orubu, E. S. F. Orubu, E.S.F. Orubu, ESF Orubu, Ebiowei S F Orubu, Ebiowei S. F. Orubu, Ebiowei S.F Orubu, Ebiowei S.F. Orubu, Ebiowei SF Orubu, Ebiowei Samuel F. Orubu, Ebiowei Samuel Orubu, Orubu S.F. Ebiowei, Orubu, Ebiowei Samuel, Samuel Orubu

Observed institutions: Boston University, Niger Delta University, York University, Health Systems Global, UCL School of Pharmacy, University College London

ORCID: 0000-0003-4455-5801

Observed ORCID: 0000-0003-4455-5801

OpenAlex ID: A5009609932

Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism

2020 · Emmanuel Amabebe, Faith O. Robert, et al. · British Journal Of Nutrition · 482

Access to medicines through health systems in low- and middle-income countries

2019 · Sachiko Ozawa, Raja Shankar, et al. · Health Policy and Planning · 154

Patient Access in 14 High-Income Countries to New Antibacterials Approved by the US Food and Drug Administration, European Medicines Agency, Japanese Pharmaceuticals and Medical Devices Agency, or Health Canada, 2010–2020

2021 · Kevin Outterson, Ebiowei S F Orubu, et al. · Clinical Infectious Diseases · 77

Waves of attention: patterns and themes of international antimicrobial resistance reports, 1945–2020

2021 · Kristen Overton, Nicolas Fortané, et al. · BMJ Global Health · 67

Status and implications of the knowledge, attitudes and practices towards AWaRe antibiotic use, resistance and stewardship among low- and middle-income countries

2025 · Zikria Saleem, Catrin E Moore, et al. · JAC-Antimicrobial Resistance · 65

Veterinary antimicrobial resistance containment in Bangladesh: Evaluating the national action plan and scoping the evidence on implementation

2019 · Ebiowei Samuel F. Orubu, Muhammad H. Zaman, et al. · Journal of Global Antimicrobial Resistance · 59

Medicines for children: flexible solid oral formulations

2017 · Ebiowei SF Orubu, Catherine Tuleu · Bulletin of the World Health Organization · 51

Tackling the blind spot of poor-quality medicines in Universal Health Coverage

2020 · E. S. F. Orubu, C. Ching, et al. · Journal of Pharmaceutical Policy and Practice · 46

Current access, availability and use of antibiotics in primary care among key low- and middle-income countries and the policy implications

2025 · Zikria Saleem, Biset Asrade Mekonnen, et al. · Expert Review of Anti-infective Therapy · 45

Mapping the Antimicrobial Supply Chain in Bangladesh: A Scoping-Review-Based Ecological Assessment Approach

2021 · E.S.F. Orubu, M.A. Samad, et al. · Global Health Science and Practice · 39

The Current States, Challenges, Ongoing Efforts, and Future Perspectives of Pharmaceutical Excipients in Pediatric Patients in Each Country and Region

2022 · Jumpei Saito, Anjali Agrawal, et al. · Children · 37

Drug and therapeutics committees in Nigeria: evaluation of scope and functionality

2018 · Joseph O. Fadare, Olayinka Ogunleye, et al. · Expert Review of Clinical Pharmacology · 31

Bacterial antibiotic resistance development and mutagenesis following exposure to subinhibitory concentrations of fluoroquinolones in vitro: a systematic review of the literature

2020 · Carly Ching, Ebiowei S F Orubu, et al. · JAC-Antimicrobial Resistance · 27

Higher seasonal temperature enhances the occurrence of methicillin resistance of Staphylococcus aureus in house flies (Musca domestica) under hospital and environmental settings

2021 · Md. Abdus Sobur, Md. Saiful Islam, et al. · Folia Microbiologica · 25

Assessing Antimicrobial Resistance, Utilization, and Stewardship in Yemen: An Exploratory Mixed-Methods Study

2021 · ESF Orubu, A Najwa, et al. · American Journal of Tropical Medicine and Hygiene · 24

The need for comprehensive and multidisciplinary training in substandard and falsified medicines for pharmacists

2019 · Alessandra Ferrario, Ebiowei Samuel F Orubu, et al. · BMJ Global Health · 21

WHO essential medicines for children 2011–2019: age-appropriateness of enteral formulations

2021 · Ebiowei Samuel F Orubu, Jennifer Duncan, et al. · Archives of Disease in Childhood · 20

Veterinary consumption of highest priority critically important antimicrobials and various growth promoters based on import data in Pakistan

2022 · Muhammad Umair, Samuel Orubu, et al. · PLoS ONE · 19

Access to essential cardiovascular medicines for children: a pilot study of availability, price and affordability in Nigeria

2019 · Ebiowei S F Orubu, Faith O Robert, et al. · Health Policy and Planning · 16

Bacterial antibiotic resistance development and mutagenesis following exposure to subminimal inhibitory concentrations of fluoroquinolones in vitro: a systematic literature review protocol

2019 · Carly Ching, Ebiowei S.F. Orubu, et al. · BMJ Open · 14

Simple thin layer chromatography–ultraviolet spectrophotometric method for quality assessment of binary fixed‐dose‐combinations of lamivudine/tenofovir disoproxil fumarate and lamivudine/zidovudine in tablet formulations

2020 · Edebi N. Vaikosen, Adesegun J. Kashimawo, et al. · Journal of Separation Science · 11

Benchmarking national action plans on antimicrobial resistance in eight selected LMICs: Focus on the veterinary sector strategies

2020 · Ebiowei Samuel F Orubu, Indorica Sutradhar, et al. · Journal of Global Health · 10

Off-label prescribing for children with chronic diseases in Nigeria; findings and implications

2017 · Kazeem Adeola Oshikoya, Ibrahim Adekunle Oreagba, et al. · Expert Opinion on Drug Safety · 10

Potential drug-drug interactions in paediatric outpatient prescriptions in Nigeria and implications for the future

2016 · Kazeem Adeola Oshikoya, Ibrahim Adekunle Oreagba, et al. · Expert Review of Clinical Pharmacology · 10

COVID-19 impact on AMR: a rapid scoping review, equity analysis and evidence gap map study

2025 · Fiona Emdin, Ebiowei Samuel F Orubu, et al. · BMJ Global Health · 8

Works count: 45

Citation count: 1,417

H-index: 18

I10-index: 24